Substituted indoles

US7342029B2 · kind B2 · utility

Assignee

• Sanofi-Aventis Deutschland GMBH · DE

Inventors

• Olaf Ritzeler · Bad Soden, DE
• Hans Ulrich Stilz · Frankfurt am Main, DE
• Bernhard Neises · Griesheim, DE
• Gerhard Jaehne · Frankfurt, DE
• Joerg Habermann · Roma, IT

Key dates

• Filing date: Jul 22, 2005
• Grant date: Mar 11, 2008
• Expiry date: Jul 22, 2025

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D401/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds of the formula Iare suitable for preparing pharmaceuticals for the prophylaxis and therapy of disorders in whose course an increased activity of NFκB is involved.